Low

Released on 07/02/2018

Key Learning Points

  • Bipolar disorder
  • Borderline personality disorder
  • Bulimia nervosa
  • Grandiose delusions
  • Management of mild depression
  • Sexually transmitted infection (STI) screen

References

1. DE SOUSA RT, ZANETTI MV, BRUNONI AR, MACHADO-VIEIRA R. Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics Curr Neuropharmacol [online] 2015 Sep, 13(5):616-635 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761633
2. RUCCI P, FRANK E, SCOCCO P, CALUGI S, MINIATI M, FAGIOLINI A, CASSANO GB. Treatment -Emergent Suicidal Ideation During 4 Months of Acute Management of Unipolar Major Depression with SSRI Pharmacotherapy or Interpersonal Psychotherapy in a Randomized Clinical Trial Depress Anxiety [online] 2011 Feb 9, 28(4):303-309 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079416
3. BRENT D, MELHEM N, TURECKI G. Pharmacogenomics of suicidal events Pharmacogenomics [online] 2010 Jun, 11(6):793-807 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921883
4. GARETY PA, GITTINS M, JOLLEY S, BEBBINGTON P, DUNN G, KUIPERS E, FOWLER D, FREEMAN D. Differences in Cognitive and Emotional Processes Between Persecutory and Grandiose Delusions Schizophr Bull [online] 2012 Apr 12, 39(3):629-639 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627767
5. KIRAN C, CHAUDHURY S. Understanding delusions Ind Psychiatry J [online] 2009 Jan-Jun, 18(1):3-18 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016695
6. MCGILLEY BM, PRYOR TL. Assessment and treatment of bulimia nervosa. Am Fam Physician [online] 1998 Jun, 57(11):2743-50 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/9636337
7. MOND JM. Classification of bulimic-type eating disorders: from DSM-IV to DSM-5. J Eat Disord [online] 2013:33 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/24999412
8. LEFEVRE ML, U.S. PREVENTIVE SERVICES TASK FORCE. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med [online] 2014 Dec 16, 161(12):902-10 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/25243785
9. U.S. PREVENTIVE SERVICES TASK FORCE. Screening for Syphilis Infection: Recommendation Statement Ann Fam Med [online] 2004 Jul, 2(4):362-365 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1466700
10. MOYER VA, U.S. PREVENTIVE SERVICES TASK FORCE*. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med [online] 2013 Jul 2, 159(1):51-60 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/23698354
11. WILKINS T, ZIMMERMAN D, SCHADE RR. Hepatitis B: diagnosis and treatment. Am Fam Physician [online] 2010 Apr 15, 81(8):965-72 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/20387772
12. WILKINS T, AKHTAR M, GITITU E, JALLURI C, RAMIREZ J. Diagnosis and Management of Hepatitis C. Am Fam Physician [online] 2015 Jun 15, 91(12):835-42 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/26131943
13. ZIMMERMAN M, MORGAN TA. The relationship between borderline personality disorder and bipolar disorder Dialogues Clin Neurosci [online] 2013 Jun, 15(2):155-169 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811087
14. STOFFERS J, VöLLM BA, RüCKER G, TIMMER A, HUBAND N, LIEB K. Pharmacological interventions for borderline personality disorder Cochrane Database Syst Rev [online] 2010 Jun 16:CD005653 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169794
15. HARRISON PJ, CIPRIANI A, HARMER CJ, NOBRE AC, SAUNDERS K, GOODWIN GM, GEDDES JR. Innovative approaches to bipolar disorder and its treatment Ann N Y Acad Sci [online] 2016 Apr 25, 1366(1):76-89 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850752
16. HIPPISLEY-COX J, PRINGLE M, HAMMERSLEY V, CROWN N, WYNN A, MEAL A, COUPLAND C. Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care BMJ [online] 2001 Sep 22, 323(7314):666-669 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC55927
17. KRANTZ DS, WHITTAKER KS, FRANCIS JL, RUTLEDGE T, JOHNSON BD, BARROW G, MCCLURE C, SHEPS DS, YORK K, CORNELL C, BITTNER V, VACCARINO V, ETEIBA W, PARASHAR S, VIDO DA, MERZ CN. Psychotropic Medication Use and Risk of Adverse Cardiovascular Events in Women with Suspected Coronary Artery Disease: Outcomes from the Women's Ischemia Syndrome Evaluation (WISE) Study Heart [online] 2009 Aug 6, 95(23):1901-1906 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784030
18. WANG JT, HOFFMAN B, BLUMENTHAL JA. Management of Depression in Patients with Coronary Heart Disease: Association, Mechanisms, and Treatment Implications for Depressed Cardiac Patients Expert Opin Pharmacother [online] 2010 Aug 17, 12(1):85-98 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997888
19. MAVRIDES N, NEMEROFF CB. Treatment of affective disorders in cardiac disease Dialogues Clin Neurosci [online] 2015 Jun, 17(2):127-140 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518697
20. WARNER CH, BOBO W, WARNER C, REID S, RACHAL J. Antidepressant discontinuation syndrome. Am Fam Physician [online] 2006 Aug 1, 74(3):449-56 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/16913164
21. CLAYTON AH, GOMMOLL C, CHEN D, NUNEZ R, MATHEWS M. Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial Int Clin Psychopharmacol [online] 2015 Jun 4, 30(4):216-223 [viewed 22 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457500